Stock listing
Quince Therapeutics, Inc.
Selected listing: QNCX · NASDAQ · USD · US
Quince Therapeutics, Inc. (NASDAQ:QNCX), Health Technology. Latest release Sep 17, 2026: Quince Therapeutics to Host Virtual KOL Event to Discuss the Current…
- Ticker
- NASDAQ:QNCX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Quince Therapeutics, Inc.
The company is focused on developing innovative therapies to address unmet medical needs. Quince Therapeutics aims to leverage its expertise in biotechnology to advance its product pipeline and improve patient outcomes.
Latest news from Quince Therapeutics, Inc.
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
September 17, 2026
Quince Therapeutics to Participate in September 2026 Investor Conferences
September 3, 2026
Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update
August 14, 2026
Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board
June 30, 2026
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
May 18, 2026
Research Quince Therapeutics, Inc.
Quince Therapeutics, Inc. company profile
View the public company page for Quince Therapeutics, Inc. on 6ix.
Quince Therapeutics, Inc. news
Read company news and market updates connected to Quince Therapeutics, Inc..
Quince Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Quince Therapeutics, Inc..